Additionally, this compound mediates sleep-enhancement-induced hypnosis through GABAA-benzodiazepine receptor modulation [101], and preventive and therapeutic effects against allergic rhinitis via the regulation of disease-related factors such as IgE, IL-4, NF-κB, and receptor-interacting protein 2 (RIP2), as well as eosinophils infiltration in the lungs [102]. Here, RIPK2 is linked to allergic rhinitis.